Ken Griffin's Citadel reshaped its massive portfolio in the third quarter by cutting stakes in several major tech and healthcare companies while aggressively boosting its position in Marvell Technology.
Benzinga
2 stories shown
Ken Griffin's Citadel reshaped its massive portfolio in the third quarter by cutting stakes in several major tech and healthcare companies while aggressively boosting its position in Marvell Technology.
Recent insider trades involved notable companies such as AbbVie and Prospect Capital.